Drugs that contain Fluticasone Propionate; Salmeterol Xinafoate
1. Advair Diskus 100/50 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5873360 | GLAXO GRP LTD | Inhalation device |
Feb, 2016
(8 years ago) | |
|
US5873360 (Pediatric) | GLAXO GRP LTD | Inhalation device |
Aug, 2016
(7 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-84) | Mar 31, 2012 |
| M(M-214) | Dec 20, 2020 |
Market Authorisation Date: 24 August, 2000
Treatment: NA
Dosage: POWDER;INHALATION
ADVAIR DISKUS 100/50 family patents
2. Advair Diskus 250/50 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5873360 | GLAXO GRP LTD | Inhalation device |
Feb, 2016
(8 years ago) | |
|
US5873360 (Pediatric) | GLAXO GRP LTD | Inhalation device |
Aug, 2016
(7 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-84) | Mar 31, 2012 |
| M(M-214) | Dec 20, 2020 |
Market Authorisation Date: 24 August, 2000
Treatment: NA
Dosage: POWDER;INHALATION
ADVAIR DISKUS 250/50 family patents
3. Advair Diskus 500/50 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5873360 | GLAXO GRP LTD | Inhalation device |
Feb, 2016
(8 years ago) | |
|
US5873360 (Pediatric) | GLAXO GRP LTD | Inhalation device |
Aug, 2016
(7 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-84) | Mar 31, 2012 |
| M(M-214) | Dec 20, 2020 |
Market Authorisation Date: 24 August, 2000
Treatment: NA
Dosage: POWDER;INHALATION
ADVAIR DISKUS 500/50 family patents
4. Advair Hfa patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6251368 | GLAXO GRP LTD | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
Dec, 2012
(11 years ago) | |
|
US6251368 (Pediatric) | GLAXO GRP LTD | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
Jun, 2013
(10 years ago) | |
| US6596260 | GLAXO GRP LTD | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Aug, 2014
(9 years ago) | |
| US5658549 | GLAXO GRP LTD | Aerosol formulations containing propellant 134a and fluticasone propionate |
Aug, 2014
(9 years ago) | |
| US5674472 | GLAXO GRP LTD | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
Oct, 2014
(9 years ago) | |
|
US6596260 (Pediatric) | GLAXO GRP LTD | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Feb, 2015
(9 years ago) | |
|
US5658549 (Pediatric) | GLAXO GRP LTD | Aerosol formulations containing propellant 134a and fluticasone propionate |
Feb, 2015
(9 years ago) | |
|
US5674472 (Pediatric) | GLAXO GRP LTD | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
Apr, 2015
(9 years ago) | |
| US6315173 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6966467 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6170717 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6510969 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6938796 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US6997349 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US6161724 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US6435372 | GLAXO GRP LTD | Delivery system for a medicament and method for the assembly thereof |
Jan, 2018
(6 years ago) | |
| US7143908 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US6431168 | GLAXO GRP LTD | Dispenser with doses′ counter |
Jun, 2018
(5 years ago) | |
| US7107986 | GLAXO GRP LTD | Dispenser with doses' counter |
Jun, 2018
(5 years ago) | |
|
US6315173 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6966467 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6170717 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6510969 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US7143908 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6161724 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6938796 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6435372 (Pediatric) | GLAXO GRP LTD | Delivery system for a medicament and method for the assembly thereof |
Jul, 2018
(5 years ago) | |
|
US6997349 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
| US7350676 | GLAXO GRP LTD | Valve for aerosol container |
Aug, 2018
(5 years ago) | |
|
US7107986 (Pediatric) | GLAXO GRP LTD | Dispenser with doses' counter |
Dec, 2018
(5 years ago) | |
|
US6431168 (Pediatric) | GLAXO GRP LTD | Dispenser with doses′ counter |
Dec, 2018
(5 years ago) | |
|
US7350676 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Feb, 2019
(5 years ago) | |
| US9861771 | GLAXO GRP LTD | Device housing for an aerosol container |
Oct, 2020
(3 years ago) | |
| US6743413 | GLAXO GRP LTD | Suspension aerosol formulations |
Jun, 2021
(2 years ago) | |
|
US6743413 (Pediatric) | GLAXO GRP LTD | Suspension aerosol formulations |
Dec, 2021
(2 years ago) | |
| US7832351 | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Jun, 2023
(10 months ago) | |
|
US7832351 (Pediatric) | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Dec, 2023
(4 months ago) | |
| US7500444 | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Feb, 2026
(1 year, 10 months from now) | |
|
US7500444 (Pediatric) | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Aug, 2026
(2 years from now) | |
Market Authorisation Date: 08 June, 2006
Treatment: Indicated for the long-term, twice-daily maintenance treatment of asthma in patients 12 years of age or older; Treatment of asthma in patients aged 12 years and older
Dosage: AEROSOL, METERED;INHALATION
ADVAIR HFA family patents
5. Airduo Digihaler patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6871646 | TEVA PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(2 years ago) | |
| US6701917 | TEVA PHARM | Dose counter for medicament inhaler |
Jun, 2021
(2 years ago) | |
| US6748947 | TEVA PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(2 years ago) | |
| US8006690 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Jun, 2021
(2 years ago) | |
| US6718972 | TEVA PHARM | Dose metering system for medicament inhaler |
Jun, 2021
(2 years ago) | |
| US7540282 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
May, 2023
(11 months ago) | |
|
US7540282 (Pediatric) | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Nov, 2023
(5 months ago) | |
| US9616024 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(4 months from now) | |
| US9987229 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(4 months from now) | |
|
US9616024 (Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(10 months from now) | |
|
US9987229 (Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(10 months from now) | |
| US9463288 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(1 year, 22 days from now) | |
| US10765820 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(1 year, 22 days from now) | |
|
US10765820 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(1 year, 6 months from now) | |
|
US9463288 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(1 year, 6 months from now) | |
| US8651103 | TEVA PHARM | Dry powder inhalation apparatus |
Mar, 2028
(3 years from now) | |
|
US8651103 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Sep, 2028
(4 years from now) | |
| US10195375 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2031
(6 years from now) | |
| US9731087 | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
| US10022510 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US10124131 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US9216260 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jun, 2031
(7 years from now) | |
|
US10195375 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2031
(7 years from now) | |
|
US10124131 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Nov, 2031
(7 years from now) | |
|
US10022510 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Nov, 2031
(7 years from now) | |
|
US9731087 (Pediatric) | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
Nov, 2031
(7 years from now) | |
|
US9216260 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Dec, 2031
(7 years from now) | |
| US10561808 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(7 years from now) | |
| US8978966 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jan, 2032
(7 years from now) | |
| US8714149 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2032
(7 years from now) | |
|
US10561808 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jul, 2032
(8 years from now) | |
|
US8978966 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jul, 2032
(8 years from now) | |
|
US8714149 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2032
(8 years from now) | |
| US9066957 | TEVA PHARM | Dry powder inhaler |
Oct, 2034
(10 years from now) | |
| US9415008 | TEVA PHARM | Dry powder inhaler |
Oct, 2034
(10 years from now) | |
|
US9415008 (Pediatric) | TEVA PHARM | Dry powder inhaler |
Apr, 2035
(10 years from now) | |
|
US9066957 (Pediatric) | TEVA PHARM | Dry powder inhaler |
Apr, 2035
(10 years from now) | |
| US9782550 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(11 years from now) | |
| US9782551 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(11 years from now) | |
| US10918816 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Dec, 2035
(11 years from now) | |
|
US9782551 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2036
(11 years from now) | |
|
US9782550 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2036
(11 years from now) | |
|
US10918816 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Jun, 2036
(12 years from now) | |
| US10569034 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2036
(12 years from now) | |
|
US10569034 (Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2037
(12 years from now) | |
| US11351317 | TEVA PHARM | Drug delivery device with electronics |
Feb, 2038
(13 years from now) | |
|
US11351317 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Aug, 2038
(14 years from now) | |
| US11357935 | TEVA PHARM | Drug delivery device with electronics |
Sep, 2038
(14 years from now) | |
| US11000653 | TEVA PHARM | Inhaler |
Dec, 2038
(14 years from now) | |
|
US11000653 (Pediatric) | TEVA PHARM | Inhaler |
Jun, 2039
(15 years from now) | |
| US11344685 | TEVA PHARM | Drug delivery device with electronics |
Sep, 2039
(15 years from now) | |
|
US11344685 (Pediatric) | TEVA PHARM | Drug delivery device with electronics |
Mar, 2040
(15 years from now) | |
| US11439777 | TEVA PHARM | Drug delivery device with electronics |
May, 2040
(16 years from now) | |
| US11464923 | TEVA PHARM | Inhaler system |
Jun, 2040
(16 years from now) | |
| US11173259 | TEVA PHARM | Drug delivery device with electronics and power management |
Jul, 2040
(16 years from now) | |
|
US11173259 (Pediatric) | TEVA PHARM | Drug delivery device with electronics and power management |
Jan, 2041
(16 years from now) | |
| US11266796 | TEVA PHARM | Inhalation device with integrated electronics |
Feb, 2041
(16 years from now) | |
|
US11266796 (Pediatric) | TEVA PHARM | Inhalation device with integrated electronics |
Aug, 2041
(17 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-61) | Jul 09, 2024 |
| Pediatric Exclusivity(PED) | Jan 09, 2025 |
| New Product(NP) | Jan 27, 2020 |
Market Authorisation Date: 12 July, 2019
Treatment: Treatment of asthma
Dosage: POWDER;INHALATION
AIRDUO DIGIHALER family patents
6. Airduo Respiclick patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6446627 | TEVA PHARM | Inhaler dose counter |
Dec, 2017
(6 years ago) | |
| US6748947 | TEVA PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(2 years ago) | |
| US6871646 | TEVA PHARM | De-agglomerator for breath-actuated dry powder inhaler |
Jun, 2021
(2 years ago) | |
| US6718972 | TEVA PHARM | Dose metering system for medicament inhaler |
Jun, 2021
(2 years ago) | |
| US6701917 | TEVA PHARM | Dose counter for medicament inhaler |
Jun, 2021
(2 years ago) | |
| US8006690 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Jun, 2021
(2 years ago) | |
| US7540282 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
May, 2023
(11 months ago) | |
|
US7540282 (Pediatric) | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Nov, 2023
(5 months ago) | |
| US9987229 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(4 months from now) | |
| US9616024 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(4 months from now) | |
|
US9616024 (Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(10 months from now) | |
|
US9987229 (Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(10 months from now) | |
| US9463288 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(1 year, 22 days from now) | |
| US10765820 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(1 year, 22 days from now) | |
|
US10765820 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(1 year, 6 months from now) | |
|
US9463288 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(1 year, 6 months from now) | |
| US8651103 | TEVA PHARM | Dry powder inhalation apparatus |
Mar, 2028
(3 years from now) | |
|
US8651103 (Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Sep, 2028
(4 years from now) | |
| US10195375 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2031
(6 years from now) | |
| US10022510 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(7 years from now) | |
| US10124131 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(7 years from now) | |
| US9731087 | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(7 years from now) | |
| US9216260 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jun, 2031
(7 years from now) | |
|
US10195375 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2031
(7 years from now) | |
|
US10022510 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Nov, 2031
(7 years from now) | |
|
US9731087 (Pediatric) | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
Nov, 2031
(7 years from now) | |
|
US10124131 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Nov, 2031
(7 years from now) | |
|
US9216260 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Dec, 2031
(7 years from now) | |
| US10561808 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(7 years from now) | |
| US8978966 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jan, 2032
(7 years from now) | |
| US8714149 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2032
(7 years from now) | |
|
US10561808 (Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jul, 2032
(8 years from now) | |
|
US8978966 (Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jul, 2032
(8 years from now) | |
|
US8714149 (Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2032
(8 years from now) | |
| US9066957 | TEVA PHARM | Dry powder inhaler |
Oct, 2034
(10 years from now) | |
| US9415008 | TEVA PHARM | Dry powder inhaler |
Oct, 2034
(10 years from now) | |
|
US9415008 (Pediatric) | TEVA PHARM | Dry powder inhaler |
Apr, 2035
(10 years from now) | |
|
US9066957 (Pediatric) | TEVA PHARM | Dry powder inhaler |
Apr, 2035
(10 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-61) | Jul 09, 2024 |
| Pediatric Exclusivity(PED) | Jan 09, 2025 |
| New Product(NP) | Jan 27, 2020 |
Market Authorisation Date: 12 July, 2019
Treatment: Treatment of asthma
Dosage: POWDER;INHALATION
AIRDUO RESPICLICK family patents